PREVENTIVA BOLEZNI SRCA IN ŽILJA

  • Jožica Maučec-Zakotnik Ministrstvo za zdravje Republika Slovenija Štefanova 5 1000 Ljubljana
  • Mitja Lainščak Interni oddelek Splošna bolnišnica Murska Sobota Ulica dr. Vrbnjaka 6 9000 Murska Sobota

Downloads

Download data is not yet available.

References

Sans S, Kesteloot H, Kromhout D on behalf of the Task Force. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on cardiovascular mortality and morbidity statistics in Europe. Eur Heart J 1997; 18: 1231–48.

Zdravstveni statistični letopis, Slovenija 2000. Zdrav Var 2000; 39: Suppl 1: 53–3.

Tunstall-Pedoe H, Kuulasmaa K, Mahonen M et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547–57.

The task force on the management of acute myocardial infarction of the European Society of Cardiology. Management of acute myocardial infarc

tion in patients presenting with ST-segment elevation. Eur Heart J 2002; 24: 28–66.

A report of the ACC/AHA task force on practice guidelines (Committee on the management of patients with chronic stable angina). ACC/AHA 2002 Guideline Update for the management of patients with chronic stable angina – summary article. Circulation 2003; 107: 149–58.

Libby P, Ridker PM, Maseri A. Inflammation and atheroslerosis. Circulation 2002; 105: 1135–43.

Hasdai D, Begar S, Wallentin L et al. A prospective survey of the characteristics, treatments, and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey on Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002; 23: 1190– 201.

Hunink MGM, Goldman L, Tosteson ANA et al. The recent decline in mortality from coronary heart disease, 1980–1990. The effect of secular trends in risk factors and treatment. JAMA 1997; 277: 535–42.

Lengfelder W. Primäre Prävention kardiovaskulärer Erkrankungen durch nichtpharmakologische Maßnahmen. Med Klin 2002; 97: 77–87.

Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice: the recommendations of the second joint task force of European and other Societies on coronary prevention. Eur Heart J 1998; 19: 1434–503.

EUROASPIRE I and II group. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 2001; 357: 995–1001.

Grundy SM, D’Agostino RB, Mosca L et al. Cardiovascular risk assessment based on US cohort studies: findings from a national heart, Lung, and blood institute workshop. Circulation 2001; 104: 491–6.

Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Preventiva koronarne bolezni v klinični praksi. Povzetek priporočil druge delovne skupine evropskih in drugih združenj za koronarno preventivo. Ljubljana: Združenje kardiologov Slovenije, 1998: 1–12.

Maučec-Zakotnik J, Fras Z. Ogroženost odraslih Slovencev s koronarno boleznijo. ISIS 2001; 12 (2): 47–9.

Anon. http://www.javnozdravje.com

Ur. list RS 2003; 12 (03): 4333–3.

Vartainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P. Cardiovascular risk factor changes in Finlang, 1972–1997. Int J Epidemiol 2000; 29: 49–56.

How to Cite
1.
Maučec-Zakotnik J, Lainščak M. PREVENTIVA BOLEZNI SRCA IN ŽILJA. TEST ZdravVestn [Internet]. 1 [cited 5Aug.2024];72(5). Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/1823
Section
Editorial